CVE-2026-41349: Openclaw

High severity, CVSS 8.8. EPSS: 0.8% chance of exploitation in the next 30 days.

OpenClaw before 2026.3.28 contains an agentic consent bypass vulnerability allowing LLM agents to silently disable execution approval via config.patch parameter. Remote attackers can exploit this to bypass security controls and execute unauthorized operations without user consent.

Affected products

• Openclaw Openclaw: before 2026.3.28 (fixed in 2026.3.28)

Published 2026-04-23. Last modified 2026-06-17.